Depression, Anxiety Clinical Trial
Official title:
A Pilot Study of Ba Duan Jin for Depression and Anxiety
Verified date | July 2023 |
Source | Shanghai University of Traditional Chinese Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In recent years, the number of people with symptoms of depression or anxiety are on the rise. The aims of the present study is to examine the effects of Ba Duan Jin on reducing symptoms of depression or anxiety.
Status | Active, not recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2023 |
Est. primary completion date | October 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 74 Years |
Eligibility | Inclusion Criteria: - Subject with depression or anxiety symptom diagnosed by ICD-10. - Subject is male or female, age 18 to 75. - Subject has a clear mind and the ability to read, to talk and to communicate. - Subject agrees to participate in this study and sign to the informed consent Exclusion Criteria: - Subject has severe somatic disease. - Subject has history of organic mental disorder, epilepsy, schizophrenia. - Subject takes any medication of food having effect on gut microbiota within 1 month of screening. - Subject has history of alcohol abuse. - Subject is pregnant, lactating or breast-feeding women. |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Qigong Research Institute | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai University of Traditional Chinese Medicine | Shanghai Mental Health Center |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 17-item Hamilton Depression Rating Scale | The HAMD-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores indicate more severe depression. | Change from Baseline HAMD-17 at 16 weeks | |
Primary | 14-item Hamilton Anxiety Rating Scale | The HAMA-14 is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety. | Change from Baseline HAMA-14 at 16 weeks | |
Secondary | Depression, Anxiety and Stress Scale-21 item | The DASS-21 is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively. | Baseline | |
Secondary | Depression, Anxiety and Stress Scale-21 item | The DASS-21 is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively. | 8 weeks | |
Secondary | Depression, Anxiety and Stress Scale-21 item | The DASS-21 is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively. | 16 weeks | |
Secondary | Gut microbiota | Intestinal microbiome in stool will be measured by 16S sequencing. | Baseline | |
Secondary | Gut microbiota | Intestinal microbiome in stool will be measured by 16S sequencing. | 16 weeks | |
Secondary | Traditional Chinese medicine syndrome grade | Traditional Chinese medicine(TCM) syndrome will be evaluated by TCM syndrome questionnaire. | Baseline | |
Secondary | Traditional Chinese medicine syndrome grade | Traditional Chinese medicine(TCM) syndrome will be evaluated by TCM syndrome questionnaire. | 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04122482 -
An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises
|
N/A | |
Completed |
NCT04085861 -
Mental Health in Dancers; an Intervention Study
|
N/A | |
Recruiting |
NCT06060210 -
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion
|
Phase 4 | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Recruiting |
NCT06065787 -
NeuroGlove Anxiety and Depression Study
|
N/A | |
Active, not recruiting |
NCT04583891 -
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
|
N/A | |
Completed |
NCT05554042 -
Kintsugi Voice Device Study
|
||
Not yet recruiting |
NCT06430853 -
Psychobiological Interventions in Pregnancy
|
N/A | |
Not yet recruiting |
NCT06162624 -
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
|
N/A | |
Completed |
NCT02954250 -
Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide
|
Early Phase 1 | |
Recruiting |
NCT05647499 -
Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study
|
N/A | |
Completed |
NCT03980873 -
Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach
|
N/A | |
Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT05368155 -
Chronic Pelvic Pain and Education Skills Training for Women Veterans
|
N/A | |
Completed |
NCT05455905 -
Voice Biomarkers Predictive of Depression and Anxiety
|
||
Completed |
NCT03272516 -
Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients
|
N/A | |
Not yet recruiting |
NCT05493865 -
Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Problems
|
N/A | |
Not yet recruiting |
NCT06027047 -
Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
|
||
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Recruiting |
NCT04418115 -
Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
|
N/A |